Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
108 Cards in this Set
- Front
- Back
Why is the prokaryotic 70S ribosomal complex a common antibiotic target? |
It is different enough from mammalian ribosomes to avoid most, but not all, cross-toxicity |
|
What are two subunits of a prokaryotic ribosome? |
30S (mRNA decoding)
50S (peptide synthesis) |
|
What are the two tRNA binding sites on a prokaryotic ribosome? |
P (peptidyl or donor) site
A (acceptor) site |
|
Steps in bacterial protein translation |
1) Initiation - assembly of the 70S complex
2) Early elongation - a new amino acid binds to the A site
3) Late elongation - a bond is formed between the existing peptide (at the P site) and the new amino acid (at the A site)
4) Translocation - the tRNA and peptide move from the A to the P site |
|
Is protein suppression usually bacteriostatic or bactericidal? |
Bacteriostatic |
|
How can bacteria potentially survive protein suppression? |
By going dormant |
|
Which classes of antibiotics target the 50S subunit? |
Macrolides
Chloramphenicol
Lincosamides
Streptogramins
Oxazolidinones |
|
Which classes of antibiotics target the 30S subunit? |
Aminoglycosides
Tetracyclines |
|
What are the three tetracycline subgroups? |
"Older" tetracyclines (more hydrophilic)
"Newer" tetracyclines (more hydrophobic)
Glycylcyclines |
|
What is the prototype "newer" tetracycline? |
Doxycycline |
|
What is the prototype glycylcycline? |
Tigecycline |
|
Tetracyclines inhibit which step in protein translation? |
Early elongation |
|
What is the mechanism of action of the tetracyclines? |
They bind to the 30S subunit, preventing the binding of aminoacyl tRNAs to the A site |
|
Are tetracyclines bacteriostatic or bactericidal? |
Bacteriostatic |
|
Are tetracyclines broad or narrow-spectrum? |
Broad-spectrum |
|
Why has use of tetracyclines decreased? |
Resistance |
|
What are two common mechanisms for high-level tetracycline resistance? |
Expression of efflux pumps
Ribosomal protection proteins (GTP-dependent displacement of tetracyclines from their binding site on the ribosome) |
|
How is tigecycline able to overcome tetracyline resistance? |
It is a poor pump substrate
It is not easily displaced from the ribosome |
|
What kinds of bacteria are covered by the tetracylines? |
Gram-postivie
Gram-negative
Intracellular
Spirochetes |
|
Why are tetracyclines used as alternative (and not primary) drugs for many infections? |
Resistance
Adverse effects |
|
Doxycycline is most useful for ____ and ____ pathogens |
Intracellular
Spirochete |
|
____ is most often a last-resort treatment for various multi-drug resistant pathogens |
Tigecycline |
|
Describe the pharmacokinetics of doxycycline |
Best oral bioavailability and least food interactions of the tetracyclines
Mixed renal and hepatic elimination
Good distribution, except CNS
Binds multivalent ions somewhat less than other tetracyclines |
|
Describe the pharmacokinetics of tigecycline |
Only available for injection
Mostly hepatic elimination (more lipophilic)
Very large Vd (volume of distribution) that can make it difficult to maintain desired blood levels
Tissue binding continually pulls drug out of blood, contributing to unexpected therapeutic failure and deaths during monotherapy |
|
Why should patients avoid ingesting dairy products, iron supplements, and some antacids two hours before and after taking a tetracycline? |
Tetracyclines bind multivalent ions |
|
Adverse effects of tetracyclines |
GI distress
Photosensitivity
Nephrotoxicity or hepatotoxicity (uncommon)
Discoloration of teeth (in children up to 8 years old) |
|
What is the prototypical aminoglycoside? |
Gentamicin |
|
What is the mechanism of action of gentamicin? |
It binds to and changes the conformation of the 30S subunit |
|
What translation defects are induced by gentamicin? |
1) Stops ribosomal movement at the start codon
2) Altered 30S conformation allows incorrect aminoacyl-tRNAs to bind, resulting in abnormal or truncated proteins
3) Forces premature termination |
|
Are aminoglycosides (gentamicin) bactericidal or bacteriostatic? |
Bactericidal |
|
Why are aminoglycosides (gentamicin) bactericidal? |
They result in aberrant proteins that can insert into cell membranes, causing lethal damage |
|
What are two important characteristics of aminoglycosides (gentamicin) that should be kept in mind when selecting a dosing protocol? |
Concentration-dependent killing
Long post-antibiotic effect |
|
Why is once daily dosing with aminoglycocides (gentamicin) just as effecting as traditional dosing (every 8 hours)? |
Higher peak concentrations are very effective due to concentration-dependent killing
Bacterial growth does not resume when the drug concentration falls below the MIC because of the post-antibiotic effect |
|
What mechanism is responsible for bacterial resistance to aminoglycosides (gentamicin)? |
Enzymatic inactivation (e.g. acetylation at amine sites) |
|
What kinds of bacteria are covered by aminoglycosides? |
Gram-positive
Gram-negative |
|
Why aren't anaerobic bacteria killed by aminoglycosides (gentamicin)? |
Aminoglycoside transport is facilitated by a high membrane potential, and anaerobic bacteria are too depolarized |
|
Describe the pharmacokinetics of the aminoglycosides (gentamicin) |
Not absorbed orally
Mainly renal elimination with short T1/2 (1-3 hrs)
Poor distribution (including CNS) |
|
What is the main use of aminoglycosides (gentamicin)? |
In the hospital setting for serious infections (e.g. systemic infections by Gram-negative rods) |
|
Aminoglycosides (gentamicin) are often combined with ____ for a synergistic bactericidal effect |
β-lactams |
|
Adverse effects of aminoglycosides (gentamicin) |
Nephrotoxicity (reversible unless severe)
Ototoxicity (resulting in tinnitus or high-frequency hearing loss; only partially reversible)
Vestibular toxicity (resulting in vertigo; only partially reversible)
Neuromuscular junction block (contraindicated with myasthenia gravis) |
|
Why is therapeutic drug monitoring required for the aminoglycosides (gentamicin)? |
Renal toxicity |
|
How do the aminoglycosides (gentamicin) accumulate in renal tubular epithelial cells? |
By binding to megalin (a membrane receptor) and undergoing clathrin-dependent endocytosis |
|
How can the renal toxicity of the aminoglycosides (gentamicin) be minimized? |
By keeping "trough" concentrations low
Avoiding use of other nephrotoxic drugs |
|
How does once daily dosing of the aminoglycosides (gentamicin) decrease renal toxicity? |
High concentrations of aminoglycosides saturate megalin-mediated drug uptake, leading to a net decrease in intracellular drug accumulation |
|
Chloramphenicol inhibits which step in bacterial protein translation? |
Late elongation |
|
What is the mechanism of action of chloramphenicol? |
It binds to the 50S subunit, preventing the transfer of the polypeptide chain to the waiting tRNA at the A site and preventing peptide bond formation |
|
What drugs bind the 50S subunit adjacent to chloramphenicol? Why is this important? |
Clindamycin
Macrolides
They could interfere with each other if used together |
|
What mechanism is responsible for bacterial resistance to chloramphenicol? |
Enzymatic inactivation (acetylation by chloramphenicol acetyl transferase) |
|
Is chloramphenicol broad or narrow-spectrum? |
Broad-spectrum |
|
Is chloramphenicol bactericidal or bacteriostatic? |
Bacteriostatic |
|
What kinds of bacteria are covered by chloramphenicol? |
Some Gram-negatives
Anaerobes
Intracellular (e.g. rickettsias) |
|
Describe the pharmacokinetics of chloramphenicol |
Only available as injection
Excellent distribution, including CNS and intracellular compartments
Mainly eliminated by hepatic glucuronidation |
|
What is an adverse effect of chloramphenicol in neonates? |
Gray baby syndrome |
|
Why does chloramphenicol cause gray baby syndrome? |
Slow metabolism in neonates |
|
Symptoms of gray baby syndrome |
Skin discoloration
Flaccidity
Respiratory distress
Shock |
|
What is important to remember about chloramphenicol in terms of drug interactions? |
It is a CYP inhibitor (drug interactions with anticoagulants, anti-epileptics, etc.) |
|
Adverse effects of chloramphenicol |
Idiopathic aplastic anemia (includes all formed blood elements)
Dose-dependent bone marrow depression |
|
How is chloramphenicol typically used? |
Used for complicated infections (rickettsioses, anaerobic infections, etc.) where less toxic antibiotics are either ineffective or can't be tolerated by the patient |
|
What is the prototypical lincosamide? |
Clindamycin |
|
What are topical forms of clindamycin used for? |
Acne vulgaris |
|
What are vaginal dosage forms of clindamycin used for? |
Bacterial vaginosis |
|
Clindamycin inhibits which step in bacterial protein translation? |
Late elongation |
|
What is the mechanism of action of clindamycin? |
Binds to the 50S subunit, preventing movement of the peptide from the P site to the A site and preventing peptide bond formation |
|
What mechanism is responsible for bacterial resistance to clindamycin? |
Methylation of the ribosome target by an inducible enzyme |
|
Is clindamycin broad or narrow-spectrum? |
Broad |
|
Is clindamycin bactericidal or bacteriostatic? |
Bacteriostatic |
|
What kinds of bacteria are covered by clindamycin? |
Gram-postive
Anaerobes (especially)
Also covers some protozoa |
|
Describe the pharmacokinetics of clindamycin |
Very good oral bioavailability
Eliminated mainly by hepatic oxidation
Remains in feces for a prolonged time
Well-distributed (including bone), except for CNS |
|
Adverse effects of clindamycin |
High incidence of diarrhea
Thrombocytopenia or agranulocytosis
High doses can cause neuromuscular junction block
Clostridium difficile-mediated psuedomembranous colitis |
|
How is clindamycin typically used? |
β-lactam alternative (non-MRSA and MRSA)
Anaerobic infections |
|
What is the prototypical macrolide? |
Azithromycin |
|
Macrolides inhibit which step in bacterial protein translation? |
Translocation |
|
What is the mechanism of action of the macrolides (azithromycin)? |
Macrolides bind to the 50S subunit, blocking the "exit tunnel" by which peptides leave the ribosome and stalling translation with the peptide at the A site |
|
Are macrolides (azithromycin) broad or narrow-spectrum? |
Broad-spectrum |
|
What kinds of bacteria are covered by macrolides (azithromycin)? |
Some Gram-positive
Gram-negative
Intracellular
Many atypical microbes (e.g. mycoplasma) |
|
What mechanisms are responsible for bacterial resistance to macrolides (azithromycin)? |
Enzymatic methylation of the macrolide binding site on the 50S subunit, decreasing drug affinity
Efflux of macrolides out of bacteria |
|
What advantage do ketolides have over macrolides (azithromycin)? |
They are less affected by the main bacterial resistance mechanism for the macrolides |
|
Macrolides (azithromycin) and ketolides are often the drugs of choice for ____ and ____ infections |
Mycoplasma
Chlamydiae |
|
Describe the pharmacokinetics of the macrolides (azithromycin) |
Good bioavailability (except for erythromycin)
Good distribution, except CNS
Mainly hepatic elimination
Azithromycin has notably longer T1/2 than others |
|
All macrolides except azithromycin are ____ inhibitors, meaning they... |
CYP3A4
They can elevate blood levels of anticonvulsants, anticoagulants, and immunosuppresants |
|
Adverse effects of macrolides (azithromycin) |
Ventricular arrhythmia |
|
What are the prototypical streptogramins? |
Quinupristin
Dalfopristin |
|
(Quinupristin or Dalfopristin?) is a "Group B" streptogramin |
Quinupristin |
|
(Quinupristin or Dalfopristin?) is a "Group A" streptogramin |
Dalfopristin |
|
Why are Group A and Group B streptogramins given together? |
Group A streptogramins promote the binding of group B streptogramins (synergistic effect) |
|
Which steps of bacterial protein synthesis are inhibited by the streptogramins? |
Early elongation - dalfopristin inhbits the new amino acid from binding to site A
Late elongation - quinupristin may inhibit formation of the peptide bond
Translocation - dalfopristin inhibits transfer of the tRNA/peptide from site A to site P |
|
The streptogramins bind which RNA subunit? |
50S subunit |
|
Is bacterial resistance to streptogramins common? |
No |
|
What mechanism is responsible for bacterial resistance to streptogramins? |
Enzymatic inactivation of the drug by lactonases |
|
Are streptogramins broad or narrow-spectrum? |
Narrow-spectrum |
|
What kind of bacteria is covered by the streptogramins? |
Gram-positive |
|
Are the streptogramins bactericidal or bacteriostatic? |
Can be either, depending on the species |
|
Describe the pharmacokinetics of the streptogramins |
Only available as injection
Good blood, tissue, and intersitial fluid levels
No CNS distribution
Mostly hepatic and/or biliary excretion |
|
What is important to remember about the streptogramins in terms of drug interactions? |
The are CYP3A4 inhibitors |
|
Adverse effects of streptogramins |
Significant arthralgia or myalgia
Substantial injection site irritation and thrombophlebitis |
|
How are the streptogramins typically used? |
For treatment of drug resistant Gram-positive bacteria (e.g. Staphylococcus aureus and Enterococcus faecium) |
|
What is the prototypical oxazolidinone? |
Linezolid |
|
Which step of bacterial protein translation is inhibited by linezolid? |
Initiation |
|
What is the mechanism of action of linezolid? |
It binds to the P site of the 50S subunit and prevents formation of the 70S complex |
|
Is linezolid bactericidal or bacteriostatic? |
Can be either, depending on the organism |
|
Is bacterial resistance against linezolid common? |
No |
|
What mechanisms are responsible for bacterial resistance to linezolid? |
Binding site mutation or methylation |
|
Is linezolid broad or narrow-spectrum? |
Narrow-spectrum |
|
What kind of bacteria are covered by linezolid? |
Gram-positive cocci and bacilli |
|
How is linezolid typically used? |
As an alternative treatment for multi-drug resistant Gram-positive cocci (e.g. S. pneumoniae, S. aureus, Enterococcus) |
|
Adverse effects of linezolid |
Mild to moderate thrombocytopenia or neutropenia (reversible)
Peripheral neurotoxicity (uncommon, but sometimes irreversible) |
|
Which class of drugs should linezolid never be combined with? Why? |
Antidepressants, because linezolid can increase serotonergic neurotransmission |
|
Describe the pharmacokinetics of linezolid |
Excellent oral bioavailability
Well-distributed, including CNS
Mainly non-enzymatic hepatic elimination (some renal elimination) |